A134 ANTI-IL-12/23P40 ANTIBODIES FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE

BACKGROUND: Ustekinumab (CNTO 1275) is a monoclonal antibody that targets the standard p40 subunit of cytokines interleukin-12 and interleukin-23 (IL-12/23p40), which are involved in the pathogenesis of Crohn’s disease. AIMS: To assess the efficacy and safety of anti-IL-12/23p40 antibodies for maint...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Can Assoc Gastroenterol
Huvudupphovsmän: Davies, S C, Nguyen, T, MacDonald, J, Parker, C E, Jairath, V, Reena, K
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2018
Ämnen:
Paper Sessions
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508301/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.134
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk